Isodiol International Inc Stock Canadian Securities Exchange
Equities
CA46500L1013
Pharmaceuticals
Sales 2018 | 19.14M 26.14M | Sales 2019 | 22.25M 30.39M | Capitalization | 49.96M 68.23M |
---|---|---|---|---|---|
Net income 2018 | -36M -49.17M | Net income 2019 | -126M -172M | EV / Sales 2018 | 12.6 x |
Net cash position 2018 | 15.55M 21.24M | Net Debt 2019 | 5.22M 7.13M | EV / Sales 2019 | 2.48 x |
P/E ratio 2018 |
-4.94
x | P/E ratio 2019 |
-0.37
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 17-05-23 |
Director/Board Member | - | 18-08-29 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 19-02-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 17-05-23 |
Director/Board Member | - | 18-08-29 | |
Director/Board Member | - | 18-11-20 |
1st Jan change | Capi. | |
---|---|---|
+37.15% | 6.12B | |
-16.04% | 4.44B | |
-11.16% | 3.14B | |
-1.40% | 3.03B | |
+0.12% | 2.57B | |
+38.69% | 1.87B | |
+1.11% | 1.63B | |
-10.34% | 1.62B | |
-12.97% | 1.53B |